-+ 0.00%
-+ 0.00%
-+ 0.00%

Addex Therapeutics files Form 3 initial beneficial ownership statement; Chief Medical Officer and director Roger Mills reports 785,976 common shares

Reuters·03/25/2026 20:04:23

Please log in to view news